Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Int J Gynecol Pathol. 2020 Sep;39(5):428–435. doi: 10.1097/PGP.0000000000000623

Table 1:

Summary of clinicopathologic parameters and PD-L1 expression in poorly differentiated Cervical Squamous Cell Carcinoma.

No Age Stage Margin
Status
LIV PD-L1
Tumor
CPS
1 34 I N Y N 5%
2 53 II N Y N 5%
3 36 I N N E 40%
4 57 I N Y E 5%
5 38 I N Y DE 60%
6 36 I N N DE 70%
7 54 I N Y E 5%
8 41 I N N DE 70%
9 61 IV N Y N 1%
10 62 II N Y E 20%
11 31 I N N DE 60%
12 42 I N Y E 20%
13 61 IV N Y N 0%
14 42 I N Y N 0%
15 46 II N Y E 15%
16 72 II Y Y E 5%
17 33 I N N DE 80%
18 24 I N Y E 1%
19 50 I N Y N 0%
20 33 I N N E 10%
21 73 I N N N 0%
22 59 I N N N 5%

LIV: Lymphovascular Involvement. CPS: Combined positive score.

N: Negative, E: expressed, DE: diffusely expressed. Y: yes, N: no.